Axsome Therapeutics Reports Q3 Revenue Up 51.9% to $259.7 Million
Photo: TokenPost
Axsome Therapeutics, Inc. reported third-quarter revenue of $259.7 million, a 51.9% increase from a year earlier and $10.51 million above estimates. The company recorded a GAAP loss of 25 cents per share, 38 cents better than estimates. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
